WMSA
PAND

Weiss Multi-Strategy Advisers’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-39,763
Closed -$590K – 922
2020
Q4 		$590K Buy
39,763
+4,763
+14% +$66.3K 0.01% 550
2020
Q3 		$401K Buy
+35,000
New +$598K 0.01% 497

Other funds holding PAND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PAND Position: Q1 2021 in Review

Weiss Multi-Strategy Advisers sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q1 2021, closing a stake of 39,763 shares — an estimated $590K sold.

Weiss Multi-Strategy Advisers first reported a position in PAND in Q3 2020 and held it in 2 quarters. The position peaked at $590K in Q4 2020. 75 funds tracked by Wall St. Rank hold PAND as of Q1 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 39,763 Pandion Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $590K.
  • Weiss Multi-Strategy Advisers first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's Pandion Therapeutics Inc. Common Stock position peaked at $590K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q1 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2021, filed 14 May 2021.